Financhill
Back

Enovis 10K Form

Sell
32

ENOV
Enovis

Last Price:
$37.77
Seasonality Move:
0.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENOV News And Ratings

See the #1 stock for the next 7 days that we like better than ENOV

ENOV Financial Statistics

Sales & Book Value

Annual Sales: $2.1B
Cash Flow: $35.1M
Price / Cash Flow: 0
Annual Sales: $45.86
Price / Book: 0.84

Profitability

EPS (TTM): -14.29000
Net Income (TTM): $-825.5M
Gross Margin: $1.2B
Return on Equity: -25.93%
Return on Assets: -16.06%

Enovis Earnings Forecast

Key Enovis Financial Ratios

  • The Gross Profit Margin over the past 21 years for ENOV is 56.02%.
  • The Selling, General & Administrative Expenses for ENOV have been equal to 48.74% of Gross Profit Margin.
  • The Research & Development expenses have been 4.33% of Revenue.
  • The Net Earning history of ENOV is -39.17% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 9 years.

Enovis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ENOV
Website: enovis.com

Debt

Debt-to-Equity Ratio: 0.52
Current Ratio: 2.17
Quick Ratio: 0.86

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 10.4

ENOV Technical Analysis vs Fundamental Analysis

Sell
32
Enovis (ENOV) is a Sell

Is Enovis a Buy or a Sell?

  • Enovis stock is rated a Sell
    The current Enovis [ENOV] share price is $37.76. The Score for ENOV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.